Navigation Links
Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
Date:3/2/2009

to systemic administration in blocking the asthmatic activities of IL-4 and IL-13 and has the potential to provide a breakthrough treatment for a patient population with few options."

AeroTrial is a late-stage clinical study using a dry powder formulation and follows positive clinical data from two Phase IIa studies in which Aerovant demonstrated significant benefit in asthmatics who were experimentally challenged with inhaled allergen (The Lancet 2007, 370: 1422-31). The dry powder formulation that will be used in AeroTrial was well tolerated in a recently completed Phase I study in asthmatics. By using a medication based on a protein occurring naturally in the body, AeroTrial seeks a non-steroidal solution to getting control of asthma. For more information, visit www.aerotrial.com.

Aerovant is a recombinant human IL-4 variant that is a potent inhibitor of the alpha subunit of the IL-4 receptor (IL-4R alpha), a shared component of both the IL-4 and IL-13 receptor complexes. Aerovance acquired the worldwide rights to the drug candidate when the company was formed as a spin-out of Bayer Pharmaceuticals Corporation in 2004.

Aerovance Inc. is a Berkeley, California-based biopharmaceutical company focused on the development and commercialization of first-in-class therapies for the treatment of respiratory and inflammatory diseases. For more information, visit www.aerovance.com.

Contact: Andreas Marathovouniotis or David Schull

Russo Partners

212-845-4235 or 212-845-4271

andreas.marathis@russopart
'/>"/>

SOURCE Aerovance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Aufgrund der enormen Nachfrage seines ... aktualisiert, der jetzt auch die Jahre 2014 - ... pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit und den ... Für international tätige Unternehmen geht es ... sondern darum, "wann" sie die neu in Kraft ...
(Date:9/19/2014)... Intarcia Therapeutics, Inc. today announced ... lead candidate ITCA 650 (continuous subcutaneous delivery of exenatide) ... levels at the 50 th Annual Meeting of ... Data from the open-label, phase 3 FREEDOM-HBL (high baseline) ... patients with poorly controlled type 2 diabetes. The results ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. , ... Inc. (PGDx), a provider of advanced cancer genome ... , a leader in discovering and developing highly ... disclosed the first-ever comprehensive genomic study of malignant ... cancer of the female reproductive system, also known ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
...  BioSurplus announced today the addition of 8000 square ... space, located next to the company,s flagship showroom, ... company,s recently launched lab equipment maintenance and repair ... In celebration of the expansion, and ...
... 2012  ProUroCare Medical Inc. (OCTBB: PUMD), provider of ... received clearance from the U.S. Food & Drug ... (PMI) system.  The approval paves the way for ... documentations as an aid in detecting prostate abnormalities ...
Cached Medicine Technology:BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility 2ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System 2ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System 3
(Date:9/20/2014)... 20, 2014 The print component ... edition of the Calgary Herald, with a circulation ... of 270,000. The digital component is distributed nationally ... a network of top news sites and partner ... campaign, visit http://www.worklifebalanceinfo.ca . , The publication ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Ticket ... Grande concert tickets for her 2015 “Honeymoon Tour.” ... code ARIANA-2015 for added savings. , In early 2015, fans ... stars in the world across North America. Twenty-one-year-old Ariana Grande ... Tour,” which will take her to 25 cities across the ...
(Date:9/20/2014)... The excitement is building up once again for ... This year the Surry Arts Council will be celebrating its ... country who are still fans of the Andy Griffith Show. ... aired on CBS from 1960 through 1968. The show ranked ... history. Mount Airy, North Carolina is where the show was ...
(Date:9/20/2014)... York, NY (PRWEB) September 20, 2014 Earlier ... of their customers may have had their credit card information ... last year, spawning a slew of headline articles like ... those weren’t the only eye opening numbers. , “Most ... were stolen, almost like it’s a way to score a ...
(Date:9/20/2014)... The first federal bellwether trial of ... third week in the U.S. District Court, Northern District ... indicate that the week opened in the DePuy ... DePuy Orthopaedics vice president, who discussed the clinical testing ... hip replacement. According to Reuters, the executive stated that ...
Breaking Medicine News(10 mins):Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4
... to control behavior seems to be part of the ,culture, ... (HealthDay News) -- Many Americans in nursing homes still get ... to rein in the practice, two new studies show. , ... physical health. Since the U.S. Food and Drug Administration instituted ...
... , , , , ... Baby Einstein, has filed an open-records complaint in Washington state court ... to release records relating to two studies that examined the effects ... has been pursuing release of the experimental methods, raw data and ...
... , , FAIRVIEW, Pa., Jan. ... designer and manufacturer of custom electronic products and systems, today reported ... 2009. , For the fourth quarter of fiscal 2009, the ... share on sales of $34.1 million, compared to net income of ...
... from heart disease, researchers say, , MONDAY, Jan. 11 (HealthDay ... increase your risk of an early death from cardiovascular disease ... What,s on the television is not the problem; it,s the ... clear link between too much sitting and death from disease," ...
... Texas, Jan. 11 OrthoSynetics(TM), the ... today announced that it has partnered with the leading ... of these two industry leaders provides the ultimate practice ... some of the most successful and profitable orthodontic practices ...
... , , , , PHILADELPHIA, Jan. 11 ... more than $566,000 in a state-of-the-art inventory management system ... of stock accuracy and the Penn Customer Portal. This ... in its class in the U.S. or Europe to ...
Cached Medicine News:Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 3Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 2Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 3Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 4Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 2Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 3Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 4Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 5Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 6Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 7Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 8Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 9Health News:TV Watching May Shorten Your Life 2Health News:TV Watching May Shorten Your Life 3Health News:OrthoSynetics(TM) Adds ORTHOTRAC to Services Portfolio 2Health News:OrthoSynetics(TM) Adds ORTHOTRAC to Services Portfolio 3Health News:Penn Pharma Invests In World-Class Inventory Management System 2
Ideal for lower abdominal procedures. Comes with a left side separating zipper....
Female High Waist Briefs...
Provides upper and lower arm support. Extends to the lower arm and across the shoulders. Has two columns of hook & eye closure for added adjustability....
Provides upper and lower arm and flank support. Extends to the wrist and over the full upper back. Has a thin strap above the breast and a 3 waistband for a secure, comfortable fit. Made of soft span...
Medicine Products: